Swift Bioscience Profile
Key Indicators
- Authorised Capital ₹ 4.50 M
- Paid Up Capital ₹ 4.50 M
- Company Age 23 Year, 7 Months
- Last Filing with ROC 31 Mar 2007
- Open Charges ₹ 3.60 M
About Swift Bioscience
Swift Bioscience Private Limited (SBPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 June 2001 and has a history of 23 years and seven months. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2007. It's a company limited by shares with an authorized capital of Rs 4.50 M and a paid-up capital of Rs 4.50 M.
The company currently has active open charges totaling ₹3.60 M.
Devang Acharya, Vipulkumar Bheda, and Ashish Karia serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231GJ2001PTC039691
-
Company No.
039691
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Jun 2001
-
Date of AGM
27 Sep 2007
-
Date of Balance Sheet
31 Mar 2007
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Swift Bioscience?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Devang Acharya
|
Director | 21-Jun-2001 | Current |
|
Vipulkumar Bheda
|
Additional Director | 21-Feb-2010 | Current |
|
Ashish Karia
|
Additional Director | 21-Feb-2010 | Current |
Financial Performance of Swift Bioscience.
Enhance accessibility to Swift Bioscience's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Swift Bioscience?
Unlock access to Swift Bioscience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹3.60 M
₹0
Charges Breakdown by Lending Institutions
- Dena Bank : 0.19 Cr
- Small Industries Development Bank Of India : 0.15 Cr
- Dena Bank : 0.02 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Aug 2006 | Dena Bank | ₹0.95 M | Open |
| 31 Mar 2006 | Dena Bank | ₹0.95 M | Open |
| 22 Dec 2005 | Small Industries Development Bank Of India | ₹1.50 M | Open |
| 19 Jan 2002 | Dena Bank | ₹0.20 M | Open |
How Many Employees Work at Swift Bioscience?
Unlock and access historical data on people associated with Swift Bioscience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Swift Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Swift Bioscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
